Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Apixaban and the improved psychologic profile in frailty and disability. Myth or reality? — Stefano Fumagalli (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Apixaban and the improved psychologic profile in frailty and disability. Myth or reality?
Shared by
Giancarlo Agnelli
University of Perugia
Apixaban and the improved psychologic profile in frailty and disability. Myth or reality?
Letter
2025
en
Authors
+2 more
SF
Stefano Fumagalli
GP
Giuseppe Di Pasquale
GM
Giulio Molon
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2025
Frailty, disability and patient-reported outcomes in apixaban users
Stefano Fumagalli
,
Giuseppe Di Pasquale
,
Giulio Molon
,
Giancarlo Agnelli
,
Niccolò Marchionni
Article
2008
Targeted therapies in cancer : myth or reality?
Francesco Colotta
,
Alberto Mantovani
Article
2008
Targeted therapies in cancer: myth or reality? Introduction.
Francesco Colotta
,
Alberto Mantovani
Chapter in a book
1992
Stenting of Coronary Arteries — The Ideal Revascularization Technique: Reality, Dream, Mystery or Myth?
D. P. Foley
,
Heleen M. van Beusekom
,
Bradley H. Strauss
,
Willem J. van der Giessen
,
Patrick W. Serruys
Article
2024
Ground Truth in Classification Accuracy Assessment: Myth and Reality
Giles Foody
Geomatics
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.